Brain, Vol. 122, No. 6, 1133-1146,
June 1999
© 1999 Oxford University Press
From off-period dystonia to peak-dose chorea
The clinical spectrum of varying subthalamic nucleus activity
1 Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France, 2 Neurology Department, Christian Albrecht Universität, Kiel, Germany and 3 MRC Human Movement and Balance Unit, Queen Square, London, UK
Correspondence to:
P. Krack, Neurology Department, University of Kiel, Niemannsweg 147, 24105 Kiel, Germany E-mail: p.krack{at}neurologie.uni-kiel.de
The effect of chronic bilateral high-frequency stimulation of the subthalamic nucleus (STN) on levodopa-induced dyskinaesias was investigated in eight patients with fluctuating Parkinson's disease complicated by functionally disabling off-period dystonia. All of the patients also had severe diphasic and peak-dose chorea, so that it was possible to study the effect of high-frequency stimulation on the different types of levodopa-induced dyskinaesias. Off-period fixed dystonia was reduced by 90% and off-period pain by 66%. After acute levodopa challenge, high-frequency stimulation of the STN reduced diphasic mobile dystonia by 50% and peak-dose choreic dyskinaesias by 30%. The effect of bilateral high-frequency stimulation of the STN on the Unified Parkinson's Disease Rating Scale motor score had the same magnitude as the preoperative effect of levodopa. This allowed the levodopa dose to be reduced by 47%. The combination of reduced medication and continuous high-frequency stimulation of the STN reduced the duration of on-period diphasic and peak-dose dyskinaesias by 52% and the intensity by 68%. Acute high-frequency stimulation of the STN mimics an acute levodopa challenge, concerning both parkinsonism and dyskinaesias, and suppresses off-period dystonia. Increasing the voltage can induce repetitive dystonic dyskinaesias, mimicking diphasic levodopa-induced dyskinaesias. A further increase in voltage leads to a shift from a diphasic-pattern dystonia to a peak-dose pattern choreodystonia. Chronic high-frequency stimulation of the STN also mimics the benefit of levodopa on parkinsonism and improves all kinds of levodopa-induced dyskinaesias to varying degrees. Off-period dystonia, associated with neuronal hyperactivity in the STN is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinaesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Chronic high-frequency stimulation of the STN allows a very gradual increase in stimulation parameters with increasing beneficial effect on parkinsonism while reducing the threshold for the elicitation of stimulation-induced dyskinaesias. In parallel with improvement of parkinsonism, the levodopa dose can be gradually decreased. As diphasic dystonic dyskinaesias are improved to a greater degree than peak-dose dyskinaesias, both direct and indirect mechanisms may be involved. Peak-dose choreatic dyskinaesias, associated with little evidence of parkinsonism and thus with low neuronal activity in the STN, are improved, mostly indirectly. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum reflecting a continuous spectrum of underlying activity patterns of STN neurons.
Parkinson's disease; levodopa-induced dyskinaesias; dystonia; subthalamic nucleus; deep brain stimulation
GPi = globus pallidus internus; HFS = high-frequency stimulation; LID = levodopa-induced dyskinaesias; STN = subthalamic nucleus; UPDRS = Unified Parkinson's Disease Rating Scale
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S.J. Groiss, L. Wojtecki, M. Sudmeyer, and A. Schnitzler Review: Deep brain stimulation in Parkinson's disease Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 379 - 391. [Abstract] [PDF]
|
|
|
|
 |
|
 A. L. Ridgel, J. L. Vitek, and J. L. Alberts Forced, Not Voluntary, Exercise Improves Motor Function in Parkinson's Disease Patients Neurorehabil Neural Repair, July 1, 2009; 23(6): 600 - 608. [Abstract] [PDF]
|
|
|
|
 |
|
 C. W. Olanow, M. B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology, May 26, 2009; 72(21_Supplement_4): S1 - S136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Kataoka, M. Yanase, M. Kawahara, H. Hirabayashi, T. Yamanaka, M. Hirano, and S. Ueno Subthalamic nucleus stimulation in Parkinson's disease is associated with a risk of fixed epiglottis BMJ Case Reports, February 2, 2009; 2009(jan27_1): bcr0820080706 - bcr0820080706. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Anheim, A. Batir, V. Fraix, M. Silem, S. Chabardes, E. Seigneuret, P. Krack, A.-L. Benabid, and P. Pollak Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement: Effects of Reimplantation Arch Neurol, May 1, 2008; 65(5): 612 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Yanase, H Kataoka, M Kawahara, H Hirabayashi, T Yamanaka, M Hirano, and S Ueno Fixed epiglottis associated with subthalamic nucleus stimulation in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 332 - 333. [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Ishak, R. W. Platt, L. Joseph, J. A. Hanley, and J. J. Caro Meta-analysis of longitudinal studies Clinical Trials, October 1, 2007; 4(5): 525 - 539. [Abstract] [PDF]
|
|
|
|
|
|
P. -P. Derost, L. Ouchchane, D. Morand, M. Ulla, P. -M. Llorca, M. Barget, B. Debilly, J. -J. Lemaire, and F. Durif Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology, April 24, 2007; 68(17): 1345 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moro, Y.-Y. W. Poon, A. M. Lozano, J. A. Saint-Cyr, and A. E. Lang Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming Arch Neurol, September 1, 2006; 63(9): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Baufreton, Z.-T. Zhu, M. Garret, B. Bioulac, S. W. Johnson, and A. I. Taupignon Dopamine receptors set the pattern of activity generated in subthalamic neurons FASEB J, November 1, 2005; 19(13): 1771 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Detante, L. Vercueil, S. Thobois, E. Broussolle, N. Costes, F. Lavenne, S. Chabardes, D. Lebars, M. Vidailhet, A.-L. Benabid, et al. Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study Brain, August 1, 2004; 127(8): 1899 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Krack, A. Batir, N. Van Blercom, S. Chabardes, V. Fraix, C. Ardouin, A. Koudsie, P. D. Limousin, A. Benazzouz, J. F. LeBas, et al. Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease N. Engl. J. Med., November 13, 2003; 349(20): 1925 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Houeto, M.-L. Welter, P.-B. Bejjani, S. T. du Montcel, A.-M. Bonnet, V. Mesnage, S. Navarro, B. Pidoux, D. Dormont, P. Cornu, et al. Subthalamic Stimulation in Parkinson Disease: Intraoperative Predictive Factors Arch Neurol, May 1, 2003; 60(5): 690 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moro, R. J. A. Esselink, A. L. Benabid, and P. Pollak Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation Brain, November 1, 2002; 125(11): 2408 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T J Loher, J-M Burgunder, S Weber, R Sommerhalder, and J K Krauss Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 395 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wenzelburger, B.-R. Zhang, S. Pohle, S. Klebe, D. Lorenz, J. Herzog, H. Wilms, G. Deuschl, and P. Krack Force overflow and levodopa-induced dyskinesias in Parkinson's disease Brain, April 1, 2002; 125(4): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Manson, H. Hanagasi, K. Turner, P. N. Patsalos, P. Carey, N. Ratnaraj, and A. J. Lees Intravenous apomorphine therapy in Parkinson's disease: Clinical and pharmacokinetic observations Brain, February 1, 2001; 124(2): 331 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guridi and J. A. Obeso The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma Brain, January 1, 2001; 124(1): 5 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fraix, P. Pollak, N. Van Blercom, J. Xie, P. Krack, A. Koudsie, and A.L. Benabid Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease Neurology, December 26, 2000; 55(12): 1921 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Molinuevo, F. Valldeoriola, E. Tolosa, J. Rumia, J. Valls-Sole, H. Roldan, and E. Ferrer Levodopa Withdrawal After Bilateral Subthalamic Nucleus Stimulation in Advanced Parkinson Disease Arch Neurol, July 1, 2000; 57(7): 983 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Houeto, P. Damier, P. B. Bejjani, C. Staedler, A. M. Bonnet, I. Arnulf, B. Pidoux, D. Dormont, P. Cornu, and Y. Agid Subthalamic Stimulation in Parkinson Disease: A Multidisciplinary Approach Arch Neurol, April 1, 2000; 57(4): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Schuurman, D. A. Bosch, P. M.M. Bossuyt, G. J. Bonsel, E. J.W. van Someren, R. M.A. de Bie, M. P. Merkus, and J. D. Speelman A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor N. Engl. J. Med., February 17, 2000; 342(7): 461 - 468. [Abstract] [Full Text] [PDF]
|
|